Solano Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Solano General Information


Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Primary Office
  • 820 Heinz Avenue
  • Berkeley, CA 94710
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2019 Completed Out of Business
2. Grant 15-Jun-2014 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Solano’s complete valuation and funding history, request access »

Solano Executive Team (3)

Name Title Board Seat Contact Info
Janet Leeds Chief Executive Officer
Cynthia McMurray Co-Founder
Peter Wipf Co-Founder
To view Solano’s complete executive team members history, request access »